Incyte (INCY) Enterprise Value (2010 - 2026)
Incyte (INCY) reported Enterprise Value of -$4.0 billion for Q1 2026, down 66.72% on a YoY basis from -$12.1 billion in Q1 2025, and down 12.15% quarter-over-quarter from -$3.6 billion in Q4 2025.
Incyte (INCY) Enterprise Value (2010 - 2026) Analysis & Trends
Incyte has reported Enterprise Value for 17 years, with the latest figure at -$4.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 66.72% year-over-year to -$4.0 billion; the trailing twelve-month figure through Mar 2026 stood at -$4.0 billion (down 66.72% YoY), and the FY2025 full-year result was -$3.6 billion, down 65.92% from the prior year.
- Enterprise Value for Q1 2026 stood at -$4.0 billion, down from -$3.6 billion in the prior quarter.
- The five-year high for Enterprise Value was -$1.3 billion in Q3 2024, with the low at -$4.0 billion in Q1 2026.
- Historically, Enterprise Value has averaged -$2.9 billion across 5 years, with a median of -$3.0 billion in 2022.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 62.82% — and 2025, when it plunged 124.09%.
- Incyte's Enterprise Value stood at -$3.2 billion in 2022, then declined by 12.88% to -$3.7 billion in 2023, then soared by 40.97% to -$2.2 billion in 2024, then slumped by 65.92% to -$3.6 billion in 2025, then dropped by 12.15% to -$4.0 billion in 2026.
- The last three Enterprise Value figures came in at -$4.0 billion (Q1 2026), -$3.6 billion (Q4 2025), and -$2.9 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | -4.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.02 Bn |
| Dec 31, 2025 | -3.58 Bn |
| Sep 30, 2025 | -2.93 Bn |
| Jun 30, 2025 | -2.42 Bn |
| Mar 31, 2025 | -2.41 Bn |
| Dec 31, 2024 | -2.16 Bn |
| Sep 30, 2024 | -1.31 Bn |
| Jun 30, 2024 | -1.45 Bn |
| Mar 31, 2024 | -3.85 Bn |
| Dec 31, 2023 | -3.66 Bn |
| Sep 30, 2023 | -3.52 Bn |
| Jun 30, 2023 | -3.42 Bn |
| Mar 31, 2023 | -3.11 Bn |
| Dec 31, 2022 | -3.24 Bn |
| Sep 30, 2022 | -2.98 Bn |
| Jun 30, 2022 | -2.72 Bn |
| Mar 31, 2022 | -2.54 Bn |
| Dec 31, 2021 | -2.35 Bn |
| Sep 30, 2021 | -2.28 Bn |
| Jun 30, 2021 | -2.08 Bn |